Inventor
LU PATRICK Y
US20 patents
⚠️ This page may combine multiple inventors who share the name “LU PATRICK Y”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTRADIGM CORP
6 patentsUS7723316B2May 25, 2010
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP12 citations91
US7534878B2May 19, 2009
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP22 citations91
US7893244B2Feb 22, 2011
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP7 citations82
US7786092B2Aug 31, 2010
Composition and method of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP11 citations82
US7893243B2Feb 22, 2011
Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases
INTRADIGM CORP6 citations72
US7781414B2Aug 24, 2010
Targets for tumor growth inhibition
INTRADIGM CORP2 citations58
SIRNAOMICS INC
6 patentsUS11058779B2Jul 13, 2021
Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection
SIRNAOMICS INC18 citations82
US11697813B2Jul 11, 2023
Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis
SIRNAOMICS INC2 citations71
USRE46873EMay 29, 2018
Multi-targeted RNAi therapeutics for scarless wound healing of skin
SIRNAOMICS INC5 citations71
US12006500B2Jun 11, 2024
Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV)
SIRNAOMICS INC2 citations67
US12054714B2Aug 6, 2024
Peptide docking vehicle for targeted nucleic acid delivery
SIRNAOMICS INC1 citations61
US9868952B2Jan 16, 2018
Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza
SIRNAOMICS INC0 citations46
LU PATRICK Y
3 patentsUS9642873B2May 9, 2017
Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application
LU PATRICK Y7 citations79
US9012622B2Apr 21, 2015
Compositions and methods using siRNA molecules and siRNA cocktails for the treatment of breast cancer
LU PATRICK Y7 citations77
US8735567B2May 27, 2014
Multi-targeted RNAi therapeutics for scarless wound healing of skin
LU PATRICK Y5 citations71